Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)

• Company Description    LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. Number of Employees: 336

• Price / Volume Information    Yesterday's Closing Price: $5.80 Daily Weekly Monthly 20 Day Moving Average: 1,252,654 shares Shares Outstanding: 47.42 (millions) Market Capitalization: $275.02 (millions) Beta: 1.56 52 Week High: $15.84 52 Week Low: $3.99 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.12% -13.67% 12 Week -61.49% -65.02% Year To Date 17.17% 6.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 236 FIFTH AVENUE SUITE 400 - NEW YORK,NY 10001 USA ph: 866-351-5907 fax: - marc@lifemd.com http://www.lifemd.com

• General Corporate Information    Officers Justin Schreiber - Chief Executive Officer and Chairman Marc Benathen - Chief Financial Officer Roberto Simon - Director John Strawn - Director Joseph DiTrolio - Director Peer Information LifeMD, Inc. (CHCR) LifeMD, Inc. (ESRX) LifeMD, Inc. (MYDP) LifeMD, Inc. (COR) LifeMD, Inc. (GBCS) LifeMD, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 53216B104 SIC: 8011 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 47.42 Most Recent Split Date: 10.00 (0.20:1) Beta: 1.56 Market Capitalization: $275.02 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.15 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 690.30 Price/Cash Flow: - Price / Sales: 1.12 EPS Growth vs. Year Ago Period: 68.42% vs. Previous Quarter: -700.00% Sales Growth vs. Year Ago Period: 22.81% vs. Previous Quarter: -5.30% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -8.11 03/31/25 - -15.19 12/31/24 - -27.94 Current Ratio 06/30/25 - 0.77 03/31/25 - 0.82 12/31/24 - 0.81 Quick Ratio 06/30/25 - 0.72 03/31/25 - 0.77 12/31/24 - 0.76 Operating Margin 06/30/25 - -2.41 03/31/25 - -4.58 12/31/24 - -8.89 Net Margin 06/30/25 - -2.41 03/31/25 - -4.58 12/31/24 - -8.89 Pre-Tax Margin 06/30/25 - -1.83 03/31/25 - -4.17 12/31/24 - -8.63 Book Value 06/30/25 - 0.01 03/31/25 - -0.01 12/31/24 - -0.09 Inventory Turnover 06/30/25 - 10.47 03/31/25 - 10.74 12/31/24 - 9.75 Debt-to-Equity 06/30/25 - 9.21 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - 90.20 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©